Category: News

The participants of the 2018 BioCanRx-Cancer Stakeholder Alliance Learning Institute wish to share their Community Dissemination Report with the oncology patient and researcher community, BioCanRx, the Cancer Stakeholder Alliance, and the general public.   In this report, you will find the key research take-away messages and the Learning Institute’s group reflections on the topics listed… Read more »

It is with mixed emotions that I announce Dr. Kelley Parato, our Director of Scientific Affairs, has accepted a new position at the National Research Council. Kelley will be the Director of the NRC’s Health Challenge Program. Kelley has been with BioCanRx since the beginning and we are grateful for her years of expertise and… Read more »

By: Heather Blumenthal   It was the proverbial match made in heaven.   Jonathan Bramson’s lab at McMaster University had developed a new technology to produce immune cells that will attack multiple myeloma cells.   Jean-Sébastien Delisle’s lab at the Université de Montréal had novel methods and capacity to manufacture human immune cells that target… Read more »

“Thank you for this workshop, this was interesting and useful for my future projects!” -Feedback from Workshop Attendee     The annual Preclinical Experimental Design and Reporting workshop at the 2018 BioCanRx Summit for Cancer Immunotherapy was a success! The workshop focused on teaching methods and practices outlined by the National Institute of Health’s (NIH)… Read more »

Dear members of the BioCanRx network community,   You have no doubt heard the news from the federal government that the Networks of Centres of Excellence (NCE) program will be phased out by 2023. The a-base program funding of the NCE will be transferred to the new Tri-Agency fund as of April 2023. This new… Read more »

Written by James Han, PhD Student, University Health Network, Maartje Wouters, PhD, Post Doctoral Fellow, BC Cancer Agency, and Megan Mahoney, PhD, Manager of HQP Training Programs, BioCanRx   The 3rd Annual Summit for Cancer Immunotherapy (Summit4CI) that took place in Banff, AB, October 27-30, 2018, was a huge success! This year, we offered training… Read more »

Beautiful Banff, Alberta, was the setting for the third annual scientific conference of BioCanRx – Canada’s Immunotherapy Network. The Summit for Cancer Immunotherapy (Summit4CI) gathered more than 300 leading scientists, clinicians, trainees and economists with representatives from industry, patient groups, charities and government from October 27-30, 2018.   Summit 4CI explored the latest progress in… Read more »

The second BioCanRx-Cancer Stakeholder Alliance Learning Institute took place at this year’s Summit for Cancer Immunotherapy. This initiative brought together patient/caregiver leaders (patient scholars) and Highly Qualified Personnel (academic scholars) from the BioCanRx network in an interactive and collaborative knowledge exchange program. We asked two of the participants, a patient scholar and an academic scholar,… Read more »

By: Heather Blumenthal   Question: How do you solve the conundrum of, on the one hand, suppressing the immune systems of children with leukemia who undergo a stem cell transplant, to avoid rejection, while on the other hand, activating that same system to fight off the relapses from which half of those children will die?… Read more »

BioCanRx is looking forward to hosting HQP at this year’s Summit4CI. From helpful workshops to opportunities to “meet the experts”, there will be quite a few HQP-targeted events and activities designed to maximize learning and career development.     HQP Development Day – This year, the HQP Development Day will take place from 1-5pm on… Read more »